Eli Lilly CEO David Ricks, in his second year on the job, snared a larger pay package than those of a few of his Big Pharma peers. And it's not far shy of the amount his predecessor, John Lechleiter, hauled in for his final—and eighth—year as Lilly chief.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,